Life Sciences Tools & Services
Price
$379.29
+0.31%Market Cap
$35.4B
Day High
$380.00
Day Low
$372.97
WAT (Waters Corporation) reported a dramatic revenue surge of +91.4% YoY to $1.267B in Q2 2026, driven largely by a major acquisition that also inflated costs, flipping operating income to a -$47M loss and net income to -$72M compared to strong profitability in the prior year period.
Key risk: Acquisition Integration Risk
The dramatic expansion in total assets (+434% to $24.531B), liabilities (+251% to $9.239B), and operating cost base suggests WAT completed a very large acquisition. Failure to successfully integrate the acquired business could result in prolonged operating losses, as evidenced by the current -$47M operating loss. Integration challenges including systems, personnel, and culture could extend the period of margin compression.
Other Life Sciences Tools & Services companies